ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75
  • Home
  • Archive
  • Contact
✕

ASCO

  • Home
  • ASCO
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • AACR
  • Acute lymphoblastic leukemia (ALL)
  • Acute myeloid leukemia
  • Acute myeloid leukemia (AML)
  • Acute promyelocytic leukemia
  • Adolescents and young adults
  • Advanced melanoma
  • Advanced practice providers
  • Advocacy
  • Anal cancer
  • ARPA-H
  • Artificial intelligence (AI)
  • ASCO
  • ASTRO
  • Awards
  • AYA cancer
  • B-cell lymphoma
  • Big data
  • Biostatistics
  • Bladder cancer
  • Blood cancer
  • Blood cancers
  • Brain cancer
  • Breast cancer
  • Cancer
  • Cancer care delivery research
  • Cancer control
  • Cancer research
  • Cancer research policy
  • Cancer screening
  • Cancer surveillance
  • Cardiotoxicity
  • CBPF
  • Chemoimmunotherapy
  • Chemotherapy
  • Chronic lymphocytic leukemia
  • Chronic myelogenous leukemia
  • Chronic myeloid leukemia
  • Clinical trial
  • Clinical trials
  • Colorectal cancer
  • Colorectal liver metastases
  • ComboMATCH
  • Comis Symposium
  • Communication
  • Community oncology
  • Cooperative Group cancer research
  • Correlative science
  • COVID-19
  • CT scans
  • Data science
  • DCIS
  • De-escalation
  • Deep learning
  • DEI
  • Developmental therapeutics
  • Diversity
  • EGFR
  • Engineering
  • ESMO
  • Esophagus cancer
  • Ethics
  • Federally-funded cancer research
  • Financial hardship
  • Gallbladder cancer
  • Gastric cancer
  • Gastroesophageal junction cancer
  • GBM
  • Gender equity
  • Genetic testing
  • Genomics
  • Geriatric oncology
  • GI cancer
  • Glioblastoma
  • Glioma
  • GM-CSF
  • Green tea catechins
  • Group Meeting
  • GU cancer
  • Head and neck cancer
  • Head and neck squamous cell carcinoma
  • health care
  • Health care administration
  • Health equity
  • Hematologic malignancies
  • Hematology
  • Hepatic arterial infusion
  • HER2-positive breast cancer
  • Hormone therapy
  • Imaging
  • Immune checkpoint inhibitors
  • Immunotherapy
  • In memory
  • Institution Evaluation
  • Just-in-time clinical trials
  • Kidney cancer
  • Language
  • Leadership
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Lung inflammation
  • Lymphoblastic lymphoma
  • Lymphoma
  • Mammography
  • Mantle cell lymphoma
  • Meetings
  • Melanoma
  • Membership
  • Mentorship
  • Merkel cell carcinoma
  • Mesothelioma
  • Misinformation
  • Multiple myeloma
  • Myelodysplastic neoplasms
  • Myelodysplastic syndromes
  • Myeloid malignancies
  • Myeloma
  • myeloMATCH
  • National Cancer Act
  • Natural language processing
  • NCI
  • NCI-Designated Comprehensive Cancer Centers
  • NCI-MATCH
  • NCORP
  • NCTN Grant
  • Neuroendocrine tumors
  • NIH
  • NIPEC
  • Non-Hodgkin lymphoma
  • Non-small cell lung cancer
  • NSCLC
  • Older adults
  • Ovarian cancer
  • Pancreatic cancer
  • Pancreatic cyst
  • Pancreatic cysts
  • Pancreatic NETs
  • Pathology
  • Patient care
  • Patient registry
  • Patient reported outcomes (PROs)
  • Patient-reported outcomes
  • Penile cancer
  • Peripheral neuropathy
  • Personalized medicine
  • Personalized screening
  • Pneumonitis
  • Policy
  • Pragmatic clinical trials
  • Precision medicine
  • Precision oncology
  • PrECOG
  • Prevention
  • Prostate cancer
  • Proteasome inhibitors
  • Public-private partnerships
  • Publications
  • Quality of life
  • Racism
  • Radiation
  • Radiology
  • Rare disease
  • Real-world data
  • Recurrence
  • Renal cell
  • Renal cell carcinoma
  • Reproductive health
  • Research results
  • Retroperitoneal sarcoma
  • Sarcoma
  • Scholarship
  • Sexuality
  • Side effects
  • Smoking cessation
  • Smoldering multiple myeloma
  • Social determinants of health
  • Social genomics
  • Stomach cancer
  • Survivorship
  • Symptom control
  • Symptom management
  • Symptom science
  • Targeted therapy
  • Throat cancer
  • Thyroid cancer
  • TMIST
  • Tobacco cessation
  • Translational research
  • Urinary tract cancer
  • Vaccination
  • Women in oncology
  • Young investigators
December 19, 2025
News in Brief
December 19, 2025
Categories
  • News in Brief

News in Brief, December 2025

Timely updates on research leaders, presentations at medical meetings and more
Do you like it?
0 Read more
June 11, 2025
Dr. O'Dwyer and Dr. Schnall
June 11, 2025
Categories
  • From the Co-Chairs

From the Co-Chairs, June 2025

Grant updates; engineering and cancer research; Spring Group Meeting and ASCO highlights
Do you like it?
0 Read more
June 11, 2025
June 11, 2025
Categories
  • Trial Results

Trial Results: ECOG-ACRIN and PrECOG Research at ASCO 2025

Researchers with the ECOG-ACRIN Cancer Research Group presented a number of research findings at the 2025 ASCO Annual Meeting
Do you like it?
0 Read more
February 19, 2025
News in Brief
February 19, 2025
Categories
  • News in Brief

News in Brief, February 2025

Summaries and links to timely information about research results presented at medical meetings, recognition of research leaders, and more
Do you like it?
0 Read more
December 23, 2024
News in Brief
December 23, 2024
Categories
  • News in Brief

News in Brief, December 2024

Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
Do you like it?
0 Read more
November 25, 2024
News in Brief
November 25, 2024
Categories
  • News in Brief

News in Brief, November 2024

Do you like it?
0 Read more
July 3, 2024
Dr. O'Dwyer and Dr. Schnall
July 3, 2024
Categories
  • From the Co-Chairs

From the Co-Chairs, July 2024

GI Cancer Committee displays strong representation at ASCO; real-world data study nears activation; ECOG-ACRIN commends NCI's appointment of senior advisor for clinical research
Do you like it?
0 Read more
July 3, 2024
News in Brief
July 3, 2024
Categories
  • News in Brief

News in Brief, July 2024

Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
Do you like it?
0 Read more
June 11, 2024
Research definition
June 11, 2024
Categories
  • Trial Results

Trial Results: ECOG-ACRIN Research Round-Up – ASCO 2024 Highlights

Summaries of five ECOG-ACRIN trials presented at the 2024 American Society of Clinical Oncology Annual Meeting
Do you like it?
0 Read more
May 1, 2024
Dr. O'Dwyer and Dr. Schnall
May 1, 2024
Categories
  • From the Co-Chairs

From the Co-Chairs, May 2024

A new trial in sarcoma; MSI testing for gastroesophageal cancer; Spring Group Meeting and ASCO highlights
Do you like it?
0 Read more
May 1, 2024
May 1, 2024
Categories
  • Trial Results

ECOG-ACRIN Research at ASCO 2024

Researchers with the ECOG-ACRIN Cancer Research Group will present a wide range of research findings at the 2024 ASCO Annual Meeting
Do you like it?
0 Read more
June 30, 2023
Research definition
June 30, 2023
Categories
  • Active Clinical Trials
  • Trial Results

ECOG-ACRIN and PrECOG Research at ASCO 2023

Researchers presented numerous research abstracts and trial updates at the 2023 ASCO Annual Meeting
Do you like it?
0 Read more
12
Next page

A blog to share information with our members, staff, and the cancer research community

✕

Categories

  • From the Co-Chairs
  • Active Clinical Trials
  • Institution Spotlights
  • Special Topics
  • People
  • News in Brief
  • Trial Results
  • Active ECOG-ACRIN Trials
  • ECOG-ACRIN.org
STAY UP TO DATE

Opt in to ensure we deliver this monthly blog directly to your inbox. We will never share your email.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc